Biosimilar User Fee Program Stresses FDA/Sponsor Meetings Early And Often

Biosimilar product sponsors will have a wealth of opportunities to meet with FDA before submitting a marketing application under the agency’s inaugural biosimilar user fee agreement with industry.

The biosimilar user fee program agreement (referred to as BsUFA) allows sponsors to seek a general advisory meeting very early in a product’s development